Cargando…
Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia
Dutasteride, a dual inhibitor of both type I and II 5α-reductases, is used to treat male pattern hair loss (MPHL). However, patient response to dutasteride varies in each individual, the cause of which is yet to be identified. To identify genetic variants associated with response to dutasteride trea...
Autores principales: | Rhie, Arang, Son, Ho-Young, Kwak, Soo Jung, Lee, Seungbok, Kim, Dong Young, Lew, Bark-Lynn, Sim, Woo-Young, Seo, Jeong-Sun, Kwon, Ohsang, Kim, Jong-Il, Jo, Seong Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746394/ https://www.ncbi.nlm.nih.gov/pubmed/31525235 http://dx.doi.org/10.1371/journal.pone.0222533 |
Ejemplares similares
-
Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017) -
Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
por: Choi, Gwang Seong, et al.
Publicado: (2016) -
Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia
por: Tsai, Tsen‐Fang, et al.
Publicado: (2018) -
Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia
por: Ragi, Sara D., et al.
Publicado: (2023) -
Alopecia Neoplastica due to Gastric Adenocarcinoma Metastasis to the Scalp, Presenting as Alopecia: A Case Report and Literature Review
por: Kim, Jung-Hee, et al.
Publicado: (2014)